Glaucoma Trial, Recruiting NCT06201455 Sponsor: Sun Yat-sen University Condition: Glaucoma
Back to Glaucoma

Glaucoma Trial, Recruiting

NCT06201455
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 40 and 85 years, of any gender
  • People who have been diagnosed with primary open-angle glaucoma (a specific type of glaucoma)
  • People whose eye pressure is controlled at 24 mmHg or below, using between 1 and 4 eye drop medications to manage it
  • People whose vision field test results show no more than a moderate level of loss (confirm with trial site for exact measurement details)
  • People who have a cataract that is considered clinically significant, and whose best-corrected vision falls below a certain level on a standard eye chart (confirm with trial site for exact measurement details)
  • People who are willing to take part voluntarily, sign a consent form, and attend follow-up appointments as required by the study

Who may not be able to join:

  • People who have had any previous eye surgery or injury to the eye
  • People who have any other type of glaucoma aside from primary open-angle glaucoma (such as angle-closure glaucoma or other secondary forms)
  • People who have other serious eye conditions that could affect the measurements taken during the study
  • People whose eye has an axial length (the physical length of the eyeball) greater than 28 mm
  • People who only have functional vision in one eye, where the other eye has extremely poor vision
  • People who have serious health conditions affecting their overall general health
  • Women who are pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +86 13570166308

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
28 September 2023
Est. completion
30 September 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

IOP at 12 months after surgery.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov